ObsEva (NASDAQ:OBSV) Now Covered by Analysts at StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of ObsEva (NASDAQ:OBSV) in a research report issued on Monday. The firm set a “hold” rating on the stock.

ObsEva Price Performance

Shares of ObsEva stock opened at $0.10 on Monday. The stock has a market capitalization of $7.94 million, a P/E ratio of -0.11 and a beta of 0.68. ObsEva has a one year low of $0.08 and a one year high of $2.14. The business’s 50 day simple moving average is $0.01 and its two-hundred day simple moving average is $0.04.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.